Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide

Glioblastoma multiforme (GBM) is the most aggressive type of human primary brain tumor. The standard treatment protocol includes radiotherapy in combination with temozolomide (TMZ). Despite advances in GBM treatment, the survival time of patients diagnosed with glioma is 14.5 months. Regarding tumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Sales, Thais Torquato, Resende, Fernando Francisco Borges, Chaves, Natália Lemos, Titze-De-Almeida, Simoneide Souza, Báo, Sônia Nair, Brettas, Marcella Lemos, Titze-De-Almeida, Ricardo
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038559/
https://ncbi.nlm.nih.gov/pubmed/27698831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4992
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars